Prospective Changes in Health-Related Quality of Life and Emotional Outcomes in Kidney Transplantation over 6 Years
Table 1
Sociodemographic and clinical characteristics of study sample.
Total sample
Cadaver transplant
LRD transplant
value
(SD)/%
(SD)/%
(SD)/%
Age (years)
46.57 (14.21)
48.22 (14.67)
40.43 (10.57)
.025
Age (years) at diagnosis
31.18 (16.99)
32.81 (17.82)
25.04 (11.85)
ns
Education (years)
12.13 (4.46)
11.87 (4.80)
13.04 (2.94)
ns
Gender (% female)
41.2% (42)
39.5% (32)
47.6% (10)
ns
Ethnicity (% white)
76.5% (78)
75.3% (61)
81.0% (17)
ns
% married/cohabitating relationship
62.7% (64)
60.5% (49)
71.4% (15)
ns
% employed (f/t; p/t)
64.7% (66)
60.5% (49)
81.0% (17)
ns
% able to work
76.5% (78)
74.1% (60)
85.7% (18)
ns
Income
.012
£0–10,000
16.7% (17)
18.5% (15)
9.5% (2)
£10,001–20,000
24.5% (25)
28.4% (23)
9.5% (2)
£20,001–30,000
15.7% (16)
13.6% (11)
23.8% (5)
>£30,000
21.6% (22)
14.8% (12)
47.6% (10)
ns
% Diabetes
6% (6)
6.1% (5)
4.7% (1)
ns
% Vascular disease
21.5% (22)
22.5% (18)
19% (4)
ns
% Hypertension
67.6% (69)
67.9% (55)
66.6% (14)
ns
GFR
43.83 (20.47)
43 (20.22)
45.77 (22.14)
ns
Transplant vintage (years)
8.08 (6.88)
11.87 (4.80)
11.25 (5.90)
.017
Primary kidney disease diagnosis (% yes)
% GN
14.7% (17)
17.2% (14)
14.3% (3)
% APKD
11.8% (12)
12.3% (10)
9.5% (2)
% Reflux Nephropathy
8.8% (9)
9.8% (8)
4.76 % (1)
% Diabetes
4.9% (5)
6.2% (5)
0% (0)
% hypertension
13.7% (14)
16% (13)
4.6% (1)
% All Other
44.1% (45)
38.3% (31)
66.6% (14)
RRT: renal replacement therapies; f/t: full time; p/t: part time; ESRD-SI: end-stage renal disease severity index; GFR: glomerular filtration rate; GN: glomerulonephritis; APKD: adult polycystic kidney disease. † values indicate significance of difference between CAD and LRD samples in the respective sociodemographic variables. ANOVA or Chi-square tests were used as appropriate.
